The Efficacy of Bevacizumab Combined With m-FOLFOXIRI in Borderline Resectable Colorectal Liver Metastases
Clinical trial NCT03711240 · UNKNOWN
Trial details
- NCT number
- NCT03711240
- Sponsor
- National Cheng-Kung University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-08
- Primary completion
- 2020-10-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.